FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY PINNACLE CUP

MDR report key: 2113371 · Received May 20, 2011

Report

Report Number
1818910-2011-08937
Event Type
Injury
Date Received
May 20, 2011
Date of Event
May 3, 2010
Report Date
April 20, 2011
Manufacturer
DEPUY INTERNATIONAL, LTD.
Product Code
KWA
PMA / PMN Number
K062426
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE AS THE PRODUCT AND LOT CODES REQUIRED WERE NOT PROVIDED. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT WITH THE INFORMATION AVAILABLE. BASED ON THE INABILITY TO IDENTIFY A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT OR ADDITIONAL INFORMATION BE RECEIVED TO CHANGE THE OUTCOME OF THE PERFORMED INVESTIGATION, THE COMPLAINT WILL BE RE-OPENED.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE: IN (B)(6) OF 2009, PATIENT WAS IMPLANTED WITH A DEPUY PINNACLE HIP ON HIS RIGHT SIDE. SEVERAL MONTHS AFTER THE SURGERY, PATIENT BEGAN EXPERIENCING DISCOMFORT AND PAIN IN HIS HIPS AND GROIN AREA. IT BECAME INCREASINGLY PAINFUL FOR HIM TO WALK AND MOVE HIS LEGS. IN (B)(6) OF 2010, PATIENT HAD REVISION SURGERY TO REMOVE THE DEPUY PINNACLE HIP BECAUSE OF SWELLING AND PAIN. DURING REVISION, DOCTORS NOTED THAT PATIENT'S WHITE BLOOD COUNT WAS EXTREMELY HIGH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNKNOWN DEPUY PINNACLE CUP TOTAL HIP REPLACEMENT KWA DEPUY INTERNATIONAL, LTD. NA UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 NA Required Intervention